Camden Partners closes biotech venture capital fund focused on Maryland startups
December 21, 2017 at 14:16 PM EST
Ultimately, the Nexus Fund will invest in about 10 companies providing between $1,000 and $2.25 million per company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.